News Category: Health & Medical

Mindray(https://www.mindray.com/en/) (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has launched its best-in-class Point of Care ultrasound system TEX20 Series(https://www.mindray.com/en/products/ultrasound/point-of-care/tex20-series?utm_source=pr-newswire&utm_medium=pressrelease&utm_campaign=TEX20&utm_id=PR) at Euroanaesthesia 2022, reimagined the connected patient status assessment process in demanding situations requiring critical care and emergency medicine. TEX20 Series fundamentally changes the conventional perspective of POC ultrasound from … Continued

On June 2 and 3, 2022, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its sixth international symposium on complex arrhythmias, EPLive 2022. This year’s event had more than 1,250 people register, a record number, with more than 150 who attended in person. There were attendees from all over the globe, … Continued

To fulfill the growing need of Colorectal Cancer Screening organizations and big clinical laboratories, Sentinel Diagnostics – an Italian company focused for more than 35 years on the development and production of In Vitro Diagnostics for the most advanced Clinical Chemistry, Immunochemistry and Molecular Diagnostics platforms – announces the launch of the SENTiFIT(R) 800 Analyzer, … Continued

— Funding round led by Advent Life Sciences. New investors include Emerson Collective, SoftBank Vision Fund 2, British Patient Capital, Mubadala and the Minderoo Foundation. — Proceeds to accelerate development and scale of Proximie’s Operating System for the Operating Room – a centralized platform delivering connected surgical care Proximie ( https://proximie.com/ ), the global health … Continued

– In hospitalized patients with COVID-19 Pneumonia, the rates of clinical events among those treated with Reparixin (n=36) were statistically significantly lower than standard of care (n=19). – The study is the first evaluation of the efficacy and safety of Reparixin an IL-8 inhibitor in patients with severe COVID-19 pneumonia. – Results from the Phase … Continued